[144] Axis Capital Holders Limited SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Axis Capital Holders Limited (AXS): The filing reports a proposed sale of 2,200 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $211,200.00. The shares represent part of restricted stock that vested on 03/01/2024 (1,407 shares) and 03/01/2023 (793 shares). The filer previously sold the same 2,200 shares on 08/15/2025 in four transactions, producing combined gross proceeds of $211,463.78. The form includes the standard signer representation that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosed under Rule 144; quantity is small relative to total shares outstanding.

The filing documents an insider disposing of 2,200 common shares via a broker on the NYSE, with the securities originating from restricted stock vesting in 2023 and 2024. The reported shares outstanding are 78,173,983, so the sale equals a de minimis percentage of outstanding stock. The notice lists both the proposed sale details and actual sales on 08/15/2025 with gross proceeds reported. For investors, this is a transparency event showing insider liquidity rather than a material corporate development.

Compliance / Corporate Governance Expert

TL;DR: Filing appears to comply with Rule 144 disclosure requirements and includes required signer attestations.

The form identifies the broker, number of shares, market value, share origin (restricted stock vesting), and prior sales in the past 3 months, matching Rule 144 presentation standards. The signer affirms absence of undisclosed material adverse information. No regulatory exceptions or incomplete mandatory fields are evident in the provided content, though some issuer identity fields in the extract are blank or not shown.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2200	211200.00	78173983	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2024	Restricted stock vesting under a registered plan	Issuer			1407	03/01/2024	Not Applicable
Common	03/01/2023	Restricted stock vesting under a registered plan	Issuer			793	03/01/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL DRAPER 92 Pitts Bay Road Pembroke D0 HM 08	Common	08/15/2025	1075	103328.89
DANIEL DRAPER 92 Pitts Bay Road Pembroke D0 HM 08	Common	08/15/2025	8	768.96
DANIEL DRAPER 92 Pitts Bay Road Pembroke D0 HM 08	Common	08/15/2025	8	768.96
DANIEL DRAPER 92 Pitts Bay Road Pembroke D0 HM 08	Common	08/15/2025	1109	106596.97

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 filed for AXS report?

The filing reports a proposed sale of 2,200 common shares on the NYSE via Morgan Stanley Smith Barney with an aggregate market value listed as $211,200.00.

Where did the 2,200 shares come from?

The shares originated from restricted stock vesting: 1,407 shares vested on 03/01/2024 and 793 shares vested on 03/01/2023.

Were any shares sold in the past 3 months?

Yes. The filer sold 2,200 shares on 08/15/2025 across four transactions, with combined gross proceeds of $211,463.78.

How large is the sale relative to total shares outstanding?

The filing lists 78,173,983 shares outstanding; the 2,200-share sale is a de minimis portion of outstanding common shares.

Does the filer certify any material undisclosed information?

The signer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.